206 related articles for article (PubMed ID: 30170373)
1. The prognostic significance of hTERT overexpression in cancers: A systematic review and meta-analysis.
Wang K; Wang RL; Liu JJ; Zhou J; Li X; Hu WW; Jiang WJ; Hao NB
Medicine (Baltimore); 2018 Aug; 97(35):e11794. PubMed ID: 30170373
[TBL] [Abstract][Full Text] [Related]
2. Tetraspanin CD151 as an emerging potential poor prognostic factor across solid tumors: a systematic review and meta-analysis.
Zeng P; Wang YH; Si M; Gu JH; Li P; Lu PH; Chen MB
Oncotarget; 2017 Jan; 8(3):5592-5602. PubMed ID: 27888619
[TBL] [Abstract][Full Text] [Related]
3. Association between Alpha B-crystallin expression and prognosis in patients with solid tumors: A protocol for systematic review and meta-analysis.
Yang M; Li Y; Tian F
Medicine (Baltimore); 2021 Feb; 100(7):e24831. PubMed ID: 33607849
[TBL] [Abstract][Full Text] [Related]
4. Telomerase is an independent prognostic marker of overall survival in patients with colorectal cancer.
Bertorelle R; Briarava M; Rampazzo E; Biasini L; Agostini M; Maretto I; Lonardi S; Friso ML; Mescoli C; Zagonel V; Nitti D; De Rossi A; Pucciarelli S
Br J Cancer; 2013 Feb; 108(2):278-84. PubMed ID: 23322193
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
[TBL] [Abstract][Full Text] [Related]
6. Systematic Review and Meta-Analysis of Lysine-Specific Demethylase 1 Expression as a Prognostic Biomarker of Cancer Survival and Disease Progression.
Agboyibor C; Dong J; Effah CY; Drokow EK; Pervaiz W; Li D; Kang L; Ma X; Li J; Liu Z; Liu HM
Cancer Control; 2021; 28():10732748211051557. PubMed ID: 34802287
[TBL] [Abstract][Full Text] [Related]
7. HMGB1 overexpression as a prognostic factor for survival in cancer: a meta-analysis and systematic review.
Wu T; Zhang W; Yang G; Li H; Chen Q; Song R; Zhao L
Oncotarget; 2016 Aug; 7(31):50417-50427. PubMed ID: 27391431
[TBL] [Abstract][Full Text] [Related]
8. PBK/TOPK overexpression and survival in solid tumors: A PRISMA-compliant meta-analysis.
Xu M; Xu S
Medicine (Baltimore); 2019 Mar; 98(10):e14766. PubMed ID: 30855480
[TBL] [Abstract][Full Text] [Related]
9. Role of TSP-1 as prognostic marker in various cancers: a systematic review and meta-analysis.
Sun S; Dong H; Yan T; Li J; Liu B; Shao P; Li J; Liang C
BMC Med Genet; 2020 Jun; 21(1):139. PubMed ID: 32600280
[TBL] [Abstract][Full Text] [Related]
10. The Clinicopathological and Prognostic Significance of IDO1 Expression in Human Solid Tumors: Evidence from a Systematic Review and Meta-Analysis.
Yu CP; Fu SF; Chen X; Ye J; Ye Y; Kong LD; Zhu Z
Cell Physiol Biochem; 2018; 49(1):134-143. PubMed ID: 30134237
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological significance and prognosis of long noncoding RNA SNHG16 expression in human cancers: a meta-analysis.
Jiao R; Jiang W; Wei X; Zhang M; Zhao S; Huang G
BMC Cancer; 2020 Jul; 20(1):662. PubMed ID: 32677912
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of 8-hydroxy-2'-deoxyguanosine in solid tumors: a meta-analysis.
Qing X; Shi D; Lv X; Wang B; Chen S; Shao Z
BMC Cancer; 2019 Oct; 19(1):997. PubMed ID: 31651287
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Role of High Stathmin 1 Expression in Patients with Solid Tumors: Evidence from a Meta-Analysis.
Mao Q; Chen Z; Wang K; Xu R; Lu H; He X
Cell Physiol Biochem; 2018; 50(1):66-78. PubMed ID: 30278466
[TBL] [Abstract][Full Text] [Related]
14. Association Between Pretreatment Serum Apolipoprotein A1 and Prognosis of Solid Tumors in Chinese Population: A Systematic Review and Meta-Analysis.
Wu J; Zhang C; Zhang G; Wang Y; Zhang Z; Su W; Lyu J
Cell Physiol Biochem; 2018; 51(2):575-588. PubMed ID: 30466099
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of NEK2 in human solid tumors: a systematic review and meta-analysis.
Wang X; Chen K; Liu H; Huang Z; Chen X; Yin L
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30578380
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and clinicopathologic significance of PLIN2 in cancers: A systematic review with meta-analysis.
Li ML; Luo HY; Quan ZW; Huang LT; Wang JH
Int J Biol Markers; 2023 Mar; 38(1):3-14. PubMed ID: 36604990
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of programmed cell death-ligand 1 expression on circulating tumor cells in various cancers: A systematic review and meta-analysis.
Ouyang Y; Liu W; Zhang N; Yang X; Li J; Long S
Cancer Med; 2021 Oct; 10(20):7021-7039. PubMed ID: 34423578
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of CD146 in solid tumor: A Systematic Review and Meta-analysis.
Zeng P; Li H; Lu PH; Zhou LN; Tang M; Liu CY; Chen MB
Sci Rep; 2017 Jun; 7(1):4223. PubMed ID: 28652617
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Significance of Tumor-Infiltrating Natural Killer Cells in Solid Tumors: A Systematic Review and Meta-Analysis.
Zhang S; Liu W; Hu B; Wang P; Lv X; Chen S; Shao Z
Front Immunol; 2020; 11():1242. PubMed ID: 32714321
[No Abstract] [Full Text] [Related]
20. Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer.
Zhu CQ; Cutz JC; Liu N; Lau D; Shepherd FA; Squire JA; Tsao MS
Br J Cancer; 2006 May; 94(10):1452-9. PubMed ID: 16641908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
